Medtronic PLC (MDT)
Cash ratio
Apr 26, 2024 | Apr 28, 2023 | Apr 29, 2022 | Apr 30, 2021 | Apr 24, 2020 | ||
---|---|---|---|---|---|---|
Cash and cash equivalents | US$ in thousands | 1,284,000 | 1,543,000 | 3,714,000 | 3,593,000 | 4,140,000 |
Short-term investments | US$ in thousands | 6,721,000 | 6,416,000 | 6,859,000 | 7,224,000 | 6,808,000 |
Total current liabilities | US$ in thousands | 10,789,000 | 9,051,000 | 12,394,000 | 8,509,000 | 10,366,000 |
Cash ratio | 0.74 | 0.88 | 0.85 | 1.27 | 1.06 |
April 26, 2024 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($1,284,000K
+ $6,721,000K)
÷ $10,789,000K
= 0.74
The cash ratio of Medtronic PLC has shown a fluctuating trend over the past five years, ranging from 0.74 to 1.27. The cash ratio measures a company's ability to cover its short-term liabilities with its cash and cash equivalents. A higher cash ratio indicates a stronger ability to meet short-term obligations using cash on hand.
In the most recent year, as of April 26, 2024, the cash ratio was 0.74, indicating a decrease compared to the previous year. This suggests that Medtronic PLC may have reduced its cash reserves relative to its short-term liabilities. However, it is important to note that a cash ratio above 1.0 is generally considered healthy, as it implies the company has more cash on hand than its short-term obligations.
On the other hand, in April 30, 2021, the cash ratio was 1.27, the highest among the five years analyzed. This indicates that Medtronic PLC had a strong liquidity position at that time, with excess cash available to cover its short-term liabilities.
Overall, while the fluctuating trend in the cash ratio of Medtronic PLC suggests varying levels of liquidity over the years, maintaining a cash ratio above 1.0 would be beneficial to ensure the company's ability to meet its short-term financial obligations effectively.
Peer comparison
Apr 26, 2024